Market Cap (In USD)
247.85 Million
Revenue (In USD)
59.58 Million
Net Income (In USD)
-43.07 Million
Avg. Volume
80.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.01-0.06
- PE
- -
- EPS
- -
- Beta Value
- 1.347
- ISIN
- GB00B02LCQ05
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Manuel Llobet
- Employee Count
- -
- Website
- https://www.allergytherapeutics.com
- Ipo Date
- 2010-02-03
- Details
- Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.
More Stocks
-
CLN
-
ENTRINTEnterprise International Limited
ENTRINT
-
JETAIRWAYSJet Airways (India) Limited
JETAIRWAYS
-
290650L&C Bio Co., Ltd
290650
-
ESAFSFBESAF Small Finance Bank
ESAFSFB
-
2388
-
DGE
-
GUERGuerrilla RF, Inc.
GUER